| |
MIT Gesundheit GmbH
|
The company
MIT Gesundheit GmbH was established with the aim of offering competent management advice to discerning customers under the guiding principle of providing
entrepreneurially minded consultations for entrepreneurs.
When the company was founded more than 15 years ago, the primary focus was on “business development”; our ”Trademark exchange“ and “Product exchange” was developed especially with clients from the pharmaceutical industry in mind. The business grew very quickly; and today pharma-specific services are offered for the following areas:
- Business development
- Licensing
- Acquisitions - Medical and scientific activities
- Pharmacotoxicological and clinical reports
- PSUR
- Drug safety / pharmacovigilance
- Regulatory affairs - Quality management
- Quality assurance systems
- Audits
- Self-inspections according to AMWHV
Effective management and discussions on costs regularly become more heated when a company is faced with new challenges, especially when the overall economic situation is difficult.
The classical concepts of job cuts, in which the production area is usually and almost exclusively affected first, no longer apply today. The ideas of “lean production” have long since filtered through to all administrative levels. When fixed costs have to be reduced and rationalization reserves identified, “outsourcing” of certain operations is attracting increasing interest: Peaks can be cushioned, and only sporadically can the required special knowledge be “bought in” on a project-related basis. An increase in personnel costs is avoided while quality remains at least the same; and not infrequently an immediate reduction in costs is possible, because
Specialists for the short term save costs in the long run |
|
FVBLSKY890 15
|
|
| |
|
